Agência Nacional de Vigilância Sanitária (Anvisa)

Is Amycretin legal in Brazil?

Not approvedAmycretin is an investigational drug with no Brazilian registration

Not approved as a medicine here.

Amycretin has no entry in Anvisa's open-data medicines register (checked 2026-09-29), and no Brazilian application was found. It is still in clinical development and cannot legally be marketed in Brazil, because Anvisa requires registration before any medicine is sold.

Last verified 2026-09-29 · how we verify

Molecule

Amycretin explained →

Country

All rules in Brazil →

Amycretin elsewhere

AustraliaNot approved
CanadaNot approved
ChinaNot approved
European UnionNot approved
IndiaNot approved
JapanNot approved
MexicoNot approved
New ZealandNot approved
United Arab EmiratesNot approved
United KingdomNot approved
United StatesNot approved

Sources (1)

01Dados abertos: registro de medicamentos (DADOS_ABERTOS_MEDICAMENTOS.csv)Agência Nacional de Vigilância Sanitária (Anvisa) · 2026-09-29 · accessed 2026-09-29